180 related articles for article (PubMed ID: 35465749)
21. Prognostic and Clinicopathological Value of Human Leukocyte Antigen G in Gastrointestinal Cancers: A Meta-Analysis.
Peng Y; Xiao J; Li W; Li S; Xie B; He J; Liu C
Front Oncol; 2021; 11():642902. PubMed ID: 34055611
[TBL] [Abstract][Full Text] [Related]
22. A meta-analysis between dietary carbohydrate intake and colorectal cancer risk: evidence from 17 observational studies.
Huang J; Pan G; Jiang H; Li W; Dong J; Zhang H; Ji X; Zhu Z
Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28298476
[TBL] [Abstract][Full Text] [Related]
23. The expression of FLNA and CLU in PBMCs as a novel screening marker for hepatocellular carcinoma.
Patarat R; Riku S; Kunadirek P; Chuaypen N; Tangkijvanich P; Mutirangura A; Puttipanyalears C
Sci Rep; 2021 Jul; 11(1):14838. PubMed ID: 34290294
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of serum interleukin-10 levels in hepatocellular carcinoma patients: a systematic review and meta-analysis.
Shakiba E; Ramezani M; Sadeghi M
Clin Exp Hepatol; 2018 Mar; 4(1):35-40. PubMed ID: 29594196
[TBL] [Abstract][Full Text] [Related]
25. Anti-Cancer Effects of Lycopene in Animal Models of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Mekuria AN; Tura AK; Hagos B; Sisay M; Abdela J; Mishore KM; Motbaynor B
Front Pharmacol; 2020; 11():1306. PubMed ID: 32982734
[TBL] [Abstract][Full Text] [Related]
26. Highlights for α-fetoprotein in determining prognosis and treatment monitoring for hepatocellular carcinoma.
Xu XS; Qu K; Liu C; Zhang YL; Liu J; Song YZ; Zhang P; Liu SN; Chang HL
World J Gastroenterol; 2012 Dec; 18(48):7242-50. PubMed ID: 23326129
[TBL] [Abstract][Full Text] [Related]
27. The prognostic value of myeloid derived suppressor cell level in hepatocellular carcinoma: A systematic review and meta-analysis.
Zhang X; Fu X; Li T; Yan H
PLoS One; 2019; 14(12):e0225327. PubMed ID: 31790437
[TBL] [Abstract][Full Text] [Related]
28. Decreased circulating clusterin reflects severe liver complications after hepatoportoenterostomy of biliary atresia.
Udomsinprasert W; Poovorawan Y; Chongsrisawat V; Vejchapipat P; Honsawek S
Sci Rep; 2020 Nov; 10(1):19736. PubMed ID: 33184463
[TBL] [Abstract][Full Text] [Related]
29. Inflammatory markers in post-traumatic stress disorder: a systematic review, meta-analysis, and meta-regression.
Passos IC; Vasconcelos-Moreno MP; Costa LG; Kunz M; Brietzke E; Quevedo J; Salum G; Magalhães PV; Kapczinski F; Kauer-Sant'Anna M
Lancet Psychiatry; 2015 Nov; 2(11):1002-12. PubMed ID: 26544749
[TBL] [Abstract][Full Text] [Related]
30. The Value of Visfatin in the Prediction of Metabolic Syndrome: A Systematic Review and Meta-Analysis.
Jiang Y; Zhou L
Horm Metab Res; 2023 Sep; 55(9):610-616. PubMed ID: 36894154
[TBL] [Abstract][Full Text] [Related]
31. Clusterin/apolipoprotein J is independently associated with survival in patients with chronic heart failure.
Koller L; Richter B; Winter MP; Sulzgruber P; Potolidis C; Liebhart F; Mörtl D; Berger R; Goliasch G; Lang I; Wojta J; Hülsmann M; Niessner A
J Clin Lipidol; 2017; 11(1):178-184. PubMed ID: 28391884
[TBL] [Abstract][Full Text] [Related]
32. Clusterin contributes to hepatitis C virus-related hepatocellular carcinoma by regulating autophagy.
Fu N; Du H; Li D; Lu Y; Li W; Wang Y; Kong L; Du J; Zhao S; Ren W; Han F; Wang R; Zhang Y; Nan Y
Life Sci; 2020 Sep; 256():117911. PubMed ID: 32504756
[TBL] [Abstract][Full Text] [Related]
33. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis.
Zhang H; Gao C; Fang L; Zhao HC; Yao SK
Scand J Gastroenterol; 2013 Jan; 48(1):78-87. PubMed ID: 23137049
[TBL] [Abstract][Full Text] [Related]
34. Manganese levels and hepatocellular carcinoma: A systematic review and meta-analysis based on Asian cohort.
Chen XB; Wei YH; Chen XK; Zhong J; Zou YB; Nie JY
Medicine (Baltimore); 2019 Aug; 98(32):e16748. PubMed ID: 31393389
[TBL] [Abstract][Full Text] [Related]
35. Prognostic Value of Lactate Dehydrogenase in Patients with Hepatocellular Carcinoma: A Meta-Analysis.
Kong W; Zuo X; Liang H; Hu J; Zhang H; Wang X; Chen W
Biomed Res Int; 2018; 2018():1723184. PubMed ID: 30687735
[TBL] [Abstract][Full Text] [Related]
36. Genetic polymorphisms of glutathione S-transferase genes GSTM1, GSTT1 and risk of hepatocellular carcinoma.
Song K; Yi J; Shen X; Cai Y
PLoS One; 2012; 7(11):e48924. PubMed ID: 23185284
[TBL] [Abstract][Full Text] [Related]
37. Hepatokine levels during the first or early second trimester of pregnancy and the subsequent risk of gestational diabetes mellitus: a systematic review and meta-analysis.
Cai Z; Yang Y; Zhang J
Biomarkers; 2021 Sep; 26(6):517-531. PubMed ID: 34082623
[TBL] [Abstract][Full Text] [Related]
38. Silencing clusterin gene transcription on effects of multidrug resistance reversing of human hepatoma HepG2/ADM cells.
Zheng W; Sai W; Yao M; Gu H; Yao Y; Qian Q; Yao D
Tumour Biol; 2015 May; 36(5):3995-4003. PubMed ID: 25600802
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of clusterin expression in advanced-stage cervical cancer treated with curative intended radiotherapy.
Watari H; Kinoshita R; Han Y; Wang L; Hosaka M; Taguchi H; Tsuchiya K; Tanaka S; Shirato H; Sakuragi N
Int J Gynecol Cancer; 2012 Mar; 22(3):465-70. PubMed ID: 21633299
[TBL] [Abstract][Full Text] [Related]
40. Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity.
Yuan L; Bing Z; Yan P; Li R; Wang C; Sun X; Yang J; Shi X; Zhang Y; Yang K
Gene; 2019 Oct; 716():144025. PubMed ID: 31394177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
